TANG PRIZE/Drug developed by Tang Prize laureate plays role in COVID-19 treatment
11/25/2021 04:45 PM
Japanese immunologist Tadamitsu Kishimoto never expected that a drug he and his research team at Osaka University developed to treat rheumatoid arthritis (RA) would one day play a role in the fight against a global pandemic.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
More in TANG PRIZE
![Drugs treating diabetes, obesity can do more: Tang Prize laureates]()
Drugs treating diabetes, obesity can do more: Tang Prize laureatesSvetlana Mojsov and Jens Juul Holst, two of the laureates of the 2024 Tang Prize in Biopharmaceutical Science, said at a forum in Taichung on Tuesday that the GLP-1-based drugs their research spawned could go beyond managing diabetes and obesity.10/01/2024 08:52 PM![Tang Prize winner lauds Taiwan implementation of human rights covenants]()
Tang Prize winner lauds Taiwan implementation of human rights covenantsFormer Irish President Mary Robinson on Monday praised Taiwan's efforts to incorporate international covenants on human rights into its domestic law despite not being a signatory.09/30/2024 08:58 PM![Historian shares research into ancient Chinese myth at Tang Prize forum]()
Historian shares research into ancient Chinese myth at Tang Prize forumRenowned Taiwanese-American historian Hsu Cho-yun (許倬雲) on Monday said his work regarding the ancient Chinese myth Da Yu (大禹) was a successful example of integrating social science methodologies into historical research that helped him win the 2024 Tang Prize in Sinology.09/30/2024 01:52 PM
Latest
- Society
- Society
Taiwan issues land warning for Tropical Storm Danas
07/05/2025 09:38 PM - Culture
Hot air balloon festival kicks off in Taitung, stopped until Monday
07/05/2025 07:13 PM - Society
Airline, ferry services affected by Tropical Storm Danas
07/05/2025 07:05 PM - Business
Hon Hai reports new high for June sales in growing AI era
07/05/2025 05:18 PM